Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.
about
Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.Potential of oncolytic viruses in the treatment of multiple myeloma.The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia virus Infectivity during Infection of Starved Mouse Cells.Oncolytic Viruses for Multiple Myeloma Therapy.Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic PotencyOncolytic virus and PD-1/PD-L1 blockade combination therapy
P2860
Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Genetically Engineered Vaccini ...... aging, and Transgene Delivery.
@en
type
label
Genetically Engineered Vaccini ...... aging, and Transgene Delivery.
@en
prefLabel
Genetically Engineered Vaccini ...... aging, and Transgene Delivery.
@en
P2860
P356
P1476
Genetically Engineered Vaccini ...... aging, and Transgene Delivery.
@en
P2093
Dana Haddad
P2860
P356
10.3389/FONC.2017.00096
P577
2017-05-23T00:00:00Z